Schedule 13D ownership disclosure

Flex Pharma, Inc.

Security class unavailable · CUSIP: 33938A105

Event date: 2015-01-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,697,264
Percent of class
15.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-15-011830
Form type
SC 13D
Filer
Decoy Therapeutics Inc.
CIK
CIK 1615219
Filed
Feb 19, 2015
Reporting period
Jan 28, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub